The goal of this project is to determine whether Ki-67 testing, using newer methods, could be used as a replacement for Oncotype DX testing in selected patients with HR+/HER2- breast cancer.
Developing a TPMG Pathway for Selective Oncotype DX Testing in Early Breast Cancer
Investigator: Habel, Laurel
Funder: TPMG Delivery Science Projects Program
